MedPath
Found 1 clinical trials|View Analysis
Sort by:

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Phase 1
Recruiting
Conditions
Rectal Cancer
Interventions
First Posted Date
2024-03-08
Last Posted Date
2024-03-08
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
30
Registration Number
NCT06300489
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath